In today’s ACT Brief, we cover the FDA approval of oral Wegovy based on Phase III OASIS 4 results, recap the most-read ...

Appetite-suppressing GLP-1 tablets become accessible in January, and manufacturers and fast-food eateries may be pushed to alter more of their goods.

In the latest of a flurry of announcements ahead of the holiday period, CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.

For the millions of Americans navigating the booming landscape of weight loss medications, the weekly injection routine just ...

The new drug, simply called the Wegovy pill, marks a turning point in the modern weight-loss revolution. Until now, every ...

Says Indian launch is subject to internal decisions and due approvals from international and national regulatory authorities ...

CNN By Tricia Escobedo, Andrew Torgan, CNN Three inmates, all accused of violent crimes, are back in custody after escaping ...

Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...

Packaged food makers and fast-food chains are bracing for change as GLP-1 pills become available, following FDA approval of Novo Nordisk's Wegovy. The pills, expected to be cheaper than injections, ...

Needle-phobic obesity patients got their first workaround with the U.S. FDA clearance of Novo Nordisk A/S’ once-daily GLP-1 Wegovy (semaglutide) pill, the first of its kind.